215 related articles for article (PubMed ID: 10608487)
1. Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.
Tórsdóttir G; Kristinsson J; Sveinbjörnsdóttir S; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 1999 Nov; 85(5):239-43. PubMed ID: 10608487
[TBL] [Abstract][Full Text] [Related]
2. Copper, ceruloplasmin and superoxide dismutase (SOD) in amyotrophic lateral sclerosis.
Tórsdóttir G; Kristinsson J; Gudmundsson G; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 2000 Sep; 87(3):126-30. PubMed ID: 11068853
[TBL] [Abstract][Full Text] [Related]
3. Non-anemic iron depletion, oral iron supplementation and indices of copper status in college-aged females.
Gropper SS; Bader-Crowe DM; McAnulty LS; White BD; Keith RE
J Am Coll Nutr; 2002 Dec; 21(6):545-52. PubMed ID: 12480800
[TBL] [Abstract][Full Text] [Related]
4. Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome.
Tórsdóttir G; Kristinsson J; Hreidarsson S; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 2001 Dec; 89(6):320-5. PubMed ID: 11903959
[TBL] [Abstract][Full Text] [Related]
5. Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease . a case-control study.
Snaedal J; Kristinsson J; Gunnarsdóttir S; Olafsdóttir ; Baldvinsson M; Jóhannesson T
Dement Geriatr Cogn Disord; 1998; 9(5):239-42. PubMed ID: 9701674
[TBL] [Abstract][Full Text] [Related]
6. A low blood copper concentration is a co-morbidity burden factor in Parkinson's disease development.
Ilyechova EY; Miliukhina IV; Orlov IA; Muruzheva ZM; Puchkova LV; Karpenko MN
Neurosci Res; 2018 Oct; 135():54-62. PubMed ID: 29203265
[TBL] [Abstract][Full Text] [Related]
7. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
[TBL] [Abstract][Full Text] [Related]
8. Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans.
Iskra M; Majewski W
Biol Trace Elem Res; 2000 Jan; 73(1):55-65. PubMed ID: 10949969
[TBL] [Abstract][Full Text] [Related]
9. Ceruloplasmin and superoxide dismutase (SOD1) in Parkinson's disease: a follow-up study.
Tórsdóttir G; Sveinbjörnsdóttir S; Kristinsson J; Snaedal J; Jóhannesson T
J Neurol Sci; 2006 Feb; 241(1-2):53-8. PubMed ID: 16352311
[TBL] [Abstract][Full Text] [Related]
10. Serum copper, zinc, ceruloplasmin and superoxide dismutase in Thai overweight and obese.
Tungtrongchitr R; Pongpaew P; Phonrat B; Tungtrongchitr A; Viroonudomphol D; Vudhivai N; Schelp FP
J Med Assoc Thai; 2003 Jun; 86(6):543-51. PubMed ID: 12924803
[TBL] [Abstract][Full Text] [Related]
11. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.
Zecca L; Stroppolo A; Gatti A; Tampellini D; Toscani M; Gallorini M; Giaveri G; Arosio P; Santambrogio P; Fariello RG; Karatekin E; Kleinman MH; Turro N; Hornykiewicz O; Zucca FA
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9843-8. PubMed ID: 15210960
[TBL] [Abstract][Full Text] [Related]
12. Copper metabolism--a factor in gestational diabetes?
Loven A; Romem Y; Pelly IZ; Holcberg G; Agam G
Clin Chim Acta; 1992 Dec; 213(1-3):51-9. PubMed ID: 1477987
[TBL] [Abstract][Full Text] [Related]
13. Activities of copper,zinc-superoxide dismutase in erythrocytes and ceruloplasmin in serum in chronic ischemia of lower limbs.
Iskra M; Majewski W
Int J Clin Lab Res; 1999; 29(2):64-7. PubMed ID: 10436263
[TBL] [Abstract][Full Text] [Related]
14. [Ceruloplasmin (Cp) and iron in connection with Parkinson's disease (PD) and Alzheimer's disease (AD)].
Johannesson T; Kristinsson J; Torsdottir G; Snaedal J
Laeknabladid; 2012 Oct; 98(10):531-7. PubMed ID: 23043066
[TBL] [Abstract][Full Text] [Related]
15. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.
Thompson K; Menzies S; Muckenthaler M; Torti FM; Wood T; Torti SV; Hentze MW; Beard J; Connor J
J Neurosci Res; 2003 Jan; 71(1):46-63. PubMed ID: 12478613
[TBL] [Abstract][Full Text] [Related]
16. Superoxide dismutase and myeloperoxidase activity in polymorphonuclear leukocytes, and serum ceruloplasmin and copper levels, in psoriasis.
Doğan P; Soyuer U; Tanrikulu G
Br J Dermatol; 1989 Feb; 120(2):239-44. PubMed ID: 2538138
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of zinc and copper in patients with Parkinson's disease.
Jiménez-Jiménez FJ; Fernández-Calle P; Martínez-Vanaclocha M; Herrero E; Molina JA; Vázquez A; Codoceo R
J Neurol Sci; 1992 Oct; 112(1-2):30-3. PubMed ID: 1469436
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term penicillamine therapy on erythrocyte CuZn superoxide dismutase activity.
Marklund SL; Ek B; Steen L
Scand J Clin Lab Invest; 1984 Feb; 44(1):13-7. PubMed ID: 6701446
[TBL] [Abstract][Full Text] [Related]
19. Role of Copper Dyshomeostasis in the Pathogenesis of Parkinson's Disease.
Karpenko MN; Ilyicheva EY; Muruzheva ZM; Milyukhina IV; Orlov YA; Puchkova LV
Bull Exp Biol Med; 2018 Mar; 164(5):596-600. PubMed ID: 29577200
[TBL] [Abstract][Full Text] [Related]
20. Relevance of non-ceruloplasmin copper to oxidative stress in patients with hepatocellular carcinoma.
Geetha A; Saranya P; Annie Jeyachristy S; Surendran R; Sundaram A
Biol Trace Elem Res; 2009 Sep; 130(3):229-40. PubMed ID: 19229483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
